Liberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
Liberty Drug & Surgical is recalling 112 bags of Doxycycline IV solution because process deficiencies may have compromised sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk of serious injury (infection) due to compromised sterility in an injectable product, meeting the criteria for a Severe rating.
Plain-English summary
Liberty Drug & Surgical is recalling 112 bags of Doxycycline/0.9% NaCl 150 mg/250 mL IV solution. The recall is due to process deficiencies observed in sterile ophthalmic and injectable products that could have compromised the sterility of the product.
The affected product is a prescription-only IV bag distributed to physicians, medical facilities, and specific patients in New Jersey and New York. The recall covers specific lots with expiration dates of 07/06/15.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Doxycycline/0.9% NaCl 150 mg/250 mL IV, 250 mL bag, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.
- Manufacturer
- Liberty Drug & Surgical
- Category
- Drug — Injectable
- Affected units
- 112
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 0513215@12
- 05192015@1
- 05222015@14
- 05222015@15
- 05282015@17
- 06012015@18
- 06022015@19
- 06052015@23
- Exp 07/06/15
Distribution
Part of a larger recall action
This product is one of 25 recalled by Liberty Drug & Surgical under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Liberty Drug & Surgical
See all →- SevereLiberty Drug Recalls Papaverine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Hydroxocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Dexamethasone Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
Same hazard · sterility compromise
See all →- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighMedline Recalls Cataract Convenience Kits Due to Open Sterile Seals
FDA (Devices) · 2026-09-23
- HighMedline Myringotomy Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMedline Anesthesia Pain Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMaquet Percutaneous Insertion Kit Recalled for Sterile Barrier Integrity Issues
FDA (Devices) · 2026-09-23
Similar recalls
- SeverePharm D Solutions Recalls Oxytocin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- HighFentanyl Citrate IV Bags Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-08-17
- HighFDA Recalls OxyTOCIN IV Bags Due to Sterility Assurance Issues
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Oxytocin Injectable Due to Sterility Assurance Failure
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Oxytocin IV Bags Due to Sterility Assurance Deficiency
FDA (Drugs) · 2023-08-09
- SevereInfusion Options Recalls Oxytocin IV Solution Due to Sterility Concerns
FDA (Drugs) · 2019-08-21